Javier Anguita - Concepedia

Author

Javier Anguita

Hospital General Universitario Gregorio Marañón

Also Known As

Carolina Martínez-Laperche, J Anguita, J. Anguita, J.M. Ramirez Anguita, J.M. Ramirez Anguita, Javier Anguita, Juan Anguita, Juan Manuel Ramirez Anguita

124

Publications

Citations

H-Index

Concepts

All Affiliations

Hospital General Universitario Gregorio Marañón Universidad Complutense de Madrid Hospital Universitario La Paz Hospital Universitario Ramón y Cajal Duran i Reynals Hospital

About

Javier Anguita is an author at Hospital General Universitario Gregorio Marañón specializing in medicine, hematology, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	423
2	Blood Transplantation	5	5	149
3	Health Sciences	2	2	78
4	Biomedical Engineering	2	2	62
5	Allergy	1	1	56

Javier Anguita

Publications

841

Citations

H-Index

Page 1

	Year	Citations
Prognostic impact of minimal residual disease analysis by flow cytometry in patients with acute myeloid leukemia before and after allogeneic hemopoietic stem cell transplantation Mariana Bastos‐Oreiro, Ana Pérez‐Corral, Carolina Martínez‐Laperche, European Journal Of Haematology	2014	70
Evaluation of Minimal Residual Disease by Real-Time Quantitative PCR of Wilms’ Tumor 1 Expression in Patients with Acute Myelogenous Leukemia after Allogeneic Stem Cell Transplantation: Correlation with Flow Cytometry and Chimerism Mi Kwon, Carolina Martínez‐Laperche, María Stefanía Infante, Biology of Blood and Marrow Transplantation	2012	66
False-positive Aspergillus Antigenemia Due to Blood Product Conditioning Fluids Pablo Martín‐Rabadán, Paloma Gijón, R. Alonso Fernandez, Clinical Infectious Diseases Laboratory HematologyAllergyMedicineBlood Transfusion ComponentsBioanalysis	2012	56
A prospective randomised study of a rotary powered device (OnControl) for bone marrow aspiration and biopsy Ronan Swords, Javier Anguita, Russell A. Higgins, Journal of Clinical Pathology	2011	48
Haplo-Cord Transplantation Using CD34+ Cells from a Third-Party Donor to Speed Engraftment in High-Risk Patients with Hematologic Disorders Mi Kwon, Guiomar Bautista, Pascual Balsalobre, Biology of Blood and Marrow Transplantation Cell TherapyImmunologyCell Replacement TherapyBiomedical EngineeringRegenerative Medicine	2014	44
Posttransplant cyclophosphamide vs cyclosporin A and methotrexate as GVHD prophylaxis in matched sibling transplantation Mi Kwon, Rebeca Bailén, María Jesús Pascual-Cascón, Blood Advances Gvhd ProphylaxisImmunologyImmunotherapyPosttransplant Cyclophosphamide VsStem Cell Transplantation	2019	44
Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucel R Rojas, Ignacio Gómez‐Centurión, Rebeca Bailén, Clinical Case Reports Clinical ImmunologyImmunodeficienciesImmunologyImmune RegulationCell Death	2022	39
Blastoschizomyces Capitatus Infection in Acute Leukemia Patients Isabel Pérez-Sánchez, Javier Anguita, Pablo Martín‐Rabadán, Leukemia & lymphoma/Leukemia and lymphoma	2000	34
Next-Generation Sequencing Improves Diagnosis, Prognosis and Clinical Management of Myeloid Neoplasms Diego Carbonell, Julia Suárez‐González, María Chicano, Cancers Myeloid NeoplasmsMixed-phenotype Acute LeukemiaGeneticsImmunologyPathology	2019	34
Single Cord Blood Combined with HLA-Mismatched Third Party Donor Cells: Comparable Results to Matched Unrelated Donor Transplantation in High-Risk Patients with Hematologic Disorders Mi Kwon, Pascual Balsalobre, David Serrano, Biology of Blood and Marrow Transplantation	2012	31

Page 1